Answers are grounded in this paper and cite their sources.
Recurrence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) after kidney transplantation is relatively uncommon due to modern immunosuppressive regimens, with early recurrence being particularly rare. We present the case of a 70-year-old woman with end-stage kidney disease of uncertain etiology who developed a biopsy-proven recurrence of pauci-immune crescentic glomerulonephritis within 1 month of receiving a deceased donor kidney transplant. Her initial allograft function was excellent but was followed by a rapid rise in serum creatinine, microscopic hematuria, and proteinuria by post-operative day 20. Serology confirmed a high p-ANCA titer. She was treated with pulse steroids and rituximab, with subsequent stabilization of her kidney function. This case highlights that AAV can recur very early in the post-transplant period and underscores the critical need to maintain a high index of suspicion for recurrent or de novo pauci-immune glomerulonephritis in transplant recipients with early allograft dysfunction, especially when the cause of their native kidney disease is unclear.
No takes yet. Share an insight, caveat, or question.
Elbaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: